StockNews.com assumed coverage on shares of Veradigm (NASDAQ:MDRX – Free Report) in a research report report published on Sunday morning. The brokerage issued a hold rating on the software maker’s stock.
A number of other research analysts also recently issued reports on the company. Royal Bank of Canada decreased their price target on Veradigm from $22.00 to $11.00 and set an outperform rating for the company in a report on Friday, January 19th. Stephens reaffirmed an equal weight rating and set a $13.00 target price on shares of Veradigm in a research note on Tuesday, November 14th. Finally, Barclays started coverage on Veradigm in a research note on Wednesday, January 3rd. They set an equal weight rating and a $11.00 target price for the company. Four analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of Hold and a consensus price target of $14.00.
Veradigm Price Performance
Institutional Trading of Veradigm
Several large investors have recently made changes to their positions in MDRX. Point72 Asset Management L.P. increased its position in shares of Veradigm by 13,306.2% during the second quarter. Point72 Asset Management L.P. now owns 1,958,639 shares of the software maker’s stock worth $24,679,000 after purchasing an additional 1,944,029 shares in the last quarter. Westfield Capital Management Co. LP purchased a new stake in Veradigm in the 1st quarter valued at $19,088,000. Pacer Advisors Inc. grew its holdings in Veradigm by 108.1% in the 4th quarter. Pacer Advisors Inc. now owns 2,516,574 shares of the software maker’s stock valued at $26,399,000 after buying an additional 1,307,024 shares in the last quarter. Wellington Management Group LLP grew its holdings in Veradigm by 92.5% in the 3rd quarter. Wellington Management Group LLP now owns 2,665,814 shares of the software maker’s stock valued at $35,029,000 after buying an additional 1,281,319 shares in the last quarter. Finally, Kent Lake Capital LLC purchased a new stake in Veradigm in the 2nd quarter valued at $10,344,000.
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
- Five stocks we like better than Veradigm
- How to Calculate Stock Profit
- MarketBeat Week in Review – 2/5 – 2/9
- Investing in Vaccines 101: How to Invest in Vaccine Stocks
- Cloudflare results spark analysts reset: 25% upside ahead
- Airline Stocks – Top Airline Stocks to Buy Now
- Beyond Nvidia: The hidden stars with 200% earnings growth
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.